AOP Health Partners with Veeva to Enhance Drug Development
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 10 2026
0mins
Should l Buy VEEV?
Source: PRnewswire
Veeva Systems Inc. saw its stock price decrease by 5.01% as it crossed below the 5-day SMA, reflecting a challenging market environment.
AOP Health has announced a partnership with Veeva to standardize applications on the Veeva Vault platform, aiming to enhance operational efficiency and accelerate the development of therapies for rare diseases. This collaboration is expected to improve drug quality and compliance, thereby addressing urgent patient needs and driving growth in the healthcare sector.
The implications of this partnership are significant, as it positions Veeva to leverage its cloud technology in a critical area of healthcare, potentially leading to increased demand for its services and a stronger market presence in the future.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy VEEV?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on VEEV
Wall Street analysts forecast VEEV stock price to rise
23 Analyst Rating
16 Buy
6 Hold
1 Sell
Moderate Buy
Current: 168.250
Low
222.00
Averages
317.10
High
380.00
Current: 168.250
Low
222.00
Averages
317.10
High
380.00
About VEEV
Veeva Systems Inc. is a provider of cloud solutions for the global life sciences industry. It offers span cloud software, data and business consulting and is designed to meet the needs of its customers and strategic business functions from research and development (R&D) through commercialization. Its product categories include Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Quality Cloud unifies applications, processes and partners across content management, training, quality management, assurance and control lab solutions on the Veeva Vault platform. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. It owns Ostro, a brand engagement platform for life sciences that gives an artificial intelligence (AI)-driven chat experience.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Veeva Systems Joins S&P 500, Boosting Market Position
- S&P 500 Inclusion: Veeva Systems will join the S&P 500 on May 7, replacing Coterra Energy, a move that drove its stock price higher on May 1, reflecting market confidence in its future performance.
- Platform Migration Progress: Veeva is migrating customers to its proprietary Vault CRM system, with over 125 clients successfully transitioned, and is expected to complete this by 2029, which will significantly enhance gross margins and technical control.
- Revenue and Margin Growth: In fiscal 2026, Veeva reported revenue of $3.2 billion, up 16%, with projections for fiscal 2027 revenue reaching $3.59 billion and net income growth of 75%, showcasing strong performance in new market expansions.
- Increased Competitive Risks: Veeva's relationship with Salesforce has shifted to competition, as Salesforce launches its Life Sciences Cloud, potentially leading to price wars that could impact Veeva's market position and valuation, although its high margins and strong cash flow provide support.
See More
Investor Sentiment on Growth Stocks
- Nvidia's Strong Performance: Nvidia's stock has surged 83% over the past 12 months, with a 65% year-over-year revenue increase to $215.9 billion in fiscal year 2026, reflecting robust demand for AI chips and indicating continued growth potential in the coming years.
- Leadership in AI Chip Market: Nvidia plans to launch Vera Rubin in the second half of the year, expecting approximately $1 trillion in purchase orders by 2027, which will further solidify its leadership position in the AI chip market and attract long-term investors.
- Veeva Systems' Market Advantage: Despite facing competition, Veeva Systems dominates the cloud solutions niche in the life sciences sector, with 15 of the top 20 biopharma companies as clients, demonstrating high demand and customer stickiness for its services.
- Financial Strength and Growth Potential: Veeva Systems reported a 16% year-over-year revenue growth to $3.2 billion in fiscal year 2026, with EPS climbing 26% to $5.44, and its $20 billion addressable market provides ample room for future growth.
See More
Nvidia and Veeva Systems' Growth Potential
- Nvidia's Market Leadership: Nvidia's stock has surged 83% over the past year, with a 65% year-over-year revenue increase to $215.9 billion for fiscal year 2026, demonstrating strong financial performance and sustained demand for AI chips, positioning it to continue leading the AI market.
- Future Order Outlook: Nvidia anticipates approximately $1 trillion in combined orders for Vera Rubin and Blackwell by 2027, indicating the company's robust competitiveness and potential for future growth in the AI chip sector.
- Veeva Systems' Market Advantage: Despite facing competition, Veeva Systems dominates the cloud solutions market for life sciences, with a 16% year-over-year revenue growth to $3.2 billion in fiscal year 2026, reflecting strong demand in its niche market.
- AI Adaptability: Veeva Systems has launched an AI system aimed at boosting productivity, with a client base that includes 15 of the top 20 biopharma companies, underscoring its significance in the industry and ample room for future growth.
See More
Two Growth Stocks Worth Investing $500 Right Now
- Nvidia's Market Performance: Nvidia's stock has surged 83% over the past year, with a 65% year-over-year revenue increase to $215.9 billion for fiscal year 2026, indicating strong financial results and sustained demand for AI chips, suggesting continued market leadership in the coming years.
- Future Potential of AI Chips: Nvidia plans to launch Vera Rubin in the second half of the year, expecting around $1 trillion in orders by 2027, which not only solidifies its leadership in the AI chip market but also reflects the company's confidence in future growth.
- Veeva Systems' Market Position: Despite competitive pressures, Veeva Systems maintains dominance in cloud solutions for the life sciences sector, with a 16% revenue growth to $3.2 billion in fiscal year 2026, demonstrating strong demand and customer loyalty in its niche market.
- AI Adaptation and Growth Potential: Veeva has launched an AI system to enhance productivity and has a massive $20 billion addressable market, indicating significant growth potential over the next five years, even as market sentiment remains cautious about its future prospects.
See More
U.S. Stocks Close: S&P 500 Hits All-Time High
- S&P 500 Strong Performance: The S&P 500 index rose by 0.29%, reaching an all-time high, driven by Apple's forecast of stronger-than-expected Q2 revenue, which boosted market sentiment and indicated increased investor confidence in tech stocks.
- Atlassian Stock Surge: Atlassian's stock soared over 29% after reporting Q3 revenue of $1.79 billion, exceeding the market expectation of $1.69 billion, highlighting a robust recovery in the software sector that may attract more investor interest.
- Oil Price Volatility Impacting Markets: WTI crude oil prices fell more than 3%, easing inflation concerns, although trade tensions resurfaced with President Trump's threat to raise tariffs on EU auto imports, potentially negatively affecting market sentiment.
- Economic Data Influencing Stocks: The April ISM manufacturing index remained unchanged at 52.7, below the expected 53.2, indicating signs of economic slowdown, despite the majority of companies reporting Q1 earnings that exceeded expectations, leaving the overall market facing uncertainty.
See More
Atlassian and Others See Significant Stock Gains
- Atlassian's Optimistic Guidance: Atlassian shares surged 23% after projecting a 24% revenue growth for the year, exceeding its previous 22% forecast and the FactSet consensus of 22.2%, indicating strong market performance and growth potential.
- nVent Electric's Strong Earnings: nVent's stock jumped 11% as first-quarter EPS and revenue surpassed Wall Street's highest estimates, with full-year revenue growth forecasted at 26% to 28%, significantly above the consensus of 18%, reflecting robust demand in data centers and energy storage.
- Cboe Global Markets Layoffs: Cboe shares rose 9% following the announcement of a 20% workforce reduction, with first-quarter adjusted EPS at $3.70 and revenue of $728.9 million, both exceeding market expectations, demonstrating the company's commitment to operational optimization.
- Roku's Revenue Beat: Roku's stock increased by 4% after reporting first-quarter revenue of $1.25 billion, surpassing the expected $1.20 billion, with adjusted EBITDA also exceeding estimates, showcasing the company's ongoing growth potential in the streaming market.
See More
Veeva Systems Joins S&P 500, Boosting Market Position
- S&P 500 Inclusion: Veeva Systems will join the S&P 500 on May 7, replacing Coterra Energy, a move that drove its stock price higher on May 1, reflecting market confidence in its future performance.
- Platform Migration Progress: Veeva is migrating customers to its proprietary Vault CRM system, with over 125 clients successfully transitioned, and is expected to complete this by 2029, which will significantly enhance gross margins and technical control.
- Revenue and Margin Growth: In fiscal 2026, Veeva reported revenue of $3.2 billion, up 16%, with projections for fiscal 2027 revenue reaching $3.59 billion and net income growth of 75%, showcasing strong performance in new market expansions.
- Increased Competitive Risks: Veeva's relationship with Salesforce has shifted to competition, as Salesforce launches its Life Sciences Cloud, potentially leading to price wars that could impact Veeva's market position and valuation, although its high margins and strong cash flow provide support.
See More
Investor Sentiment on Growth Stocks
- Nvidia's Strong Performance: Nvidia's stock has surged 83% over the past 12 months, with a 65% year-over-year revenue increase to $215.9 billion in fiscal year 2026, reflecting robust demand for AI chips and indicating continued growth potential in the coming years.
- Leadership in AI Chip Market: Nvidia plans to launch Vera Rubin in the second half of the year, expecting approximately $1 trillion in purchase orders by 2027, which will further solidify its leadership position in the AI chip market and attract long-term investors.
- Veeva Systems' Market Advantage: Despite facing competition, Veeva Systems dominates the cloud solutions niche in the life sciences sector, with 15 of the top 20 biopharma companies as clients, demonstrating high demand and customer stickiness for its services.
- Financial Strength and Growth Potential: Veeva Systems reported a 16% year-over-year revenue growth to $3.2 billion in fiscal year 2026, with EPS climbing 26% to $5.44, and its $20 billion addressable market provides ample room for future growth.
See More
Nvidia and Veeva Systems' Growth Potential
- Nvidia's Market Leadership: Nvidia's stock has surged 83% over the past year, with a 65% year-over-year revenue increase to $215.9 billion for fiscal year 2026, demonstrating strong financial performance and sustained demand for AI chips, positioning it to continue leading the AI market.
- Future Order Outlook: Nvidia anticipates approximately $1 trillion in combined orders for Vera Rubin and Blackwell by 2027, indicating the company's robust competitiveness and potential for future growth in the AI chip sector.
- Veeva Systems' Market Advantage: Despite facing competition, Veeva Systems dominates the cloud solutions market for life sciences, with a 16% year-over-year revenue growth to $3.2 billion in fiscal year 2026, reflecting strong demand in its niche market.
- AI Adaptability: Veeva Systems has launched an AI system aimed at boosting productivity, with a client base that includes 15 of the top 20 biopharma companies, underscoring its significance in the industry and ample room for future growth.
See More
Two Growth Stocks Worth Investing $500 Right Now
- Nvidia's Market Performance: Nvidia's stock has surged 83% over the past year, with a 65% year-over-year revenue increase to $215.9 billion for fiscal year 2026, indicating strong financial results and sustained demand for AI chips, suggesting continued market leadership in the coming years.
- Future Potential of AI Chips: Nvidia plans to launch Vera Rubin in the second half of the year, expecting around $1 trillion in orders by 2027, which not only solidifies its leadership in the AI chip market but also reflects the company's confidence in future growth.
- Veeva Systems' Market Position: Despite competitive pressures, Veeva Systems maintains dominance in cloud solutions for the life sciences sector, with a 16% revenue growth to $3.2 billion in fiscal year 2026, demonstrating strong demand and customer loyalty in its niche market.
- AI Adaptation and Growth Potential: Veeva has launched an AI system to enhance productivity and has a massive $20 billion addressable market, indicating significant growth potential over the next five years, even as market sentiment remains cautious about its future prospects.
See More
U.S. Stocks Close: S&P 500 Hits All-Time High
- S&P 500 Strong Performance: The S&P 500 index rose by 0.29%, reaching an all-time high, driven by Apple's forecast of stronger-than-expected Q2 revenue, which boosted market sentiment and indicated increased investor confidence in tech stocks.
- Atlassian Stock Surge: Atlassian's stock soared over 29% after reporting Q3 revenue of $1.79 billion, exceeding the market expectation of $1.69 billion, highlighting a robust recovery in the software sector that may attract more investor interest.
- Oil Price Volatility Impacting Markets: WTI crude oil prices fell more than 3%, easing inflation concerns, although trade tensions resurfaced with President Trump's threat to raise tariffs on EU auto imports, potentially negatively affecting market sentiment.
- Economic Data Influencing Stocks: The April ISM manufacturing index remained unchanged at 52.7, below the expected 53.2, indicating signs of economic slowdown, despite the majority of companies reporting Q1 earnings that exceeded expectations, leaving the overall market facing uncertainty.
See More
Atlassian and Others See Significant Stock Gains
- Atlassian's Optimistic Guidance: Atlassian shares surged 23% after projecting a 24% revenue growth for the year, exceeding its previous 22% forecast and the FactSet consensus of 22.2%, indicating strong market performance and growth potential.
- nVent Electric's Strong Earnings: nVent's stock jumped 11% as first-quarter EPS and revenue surpassed Wall Street's highest estimates, with full-year revenue growth forecasted at 26% to 28%, significantly above the consensus of 18%, reflecting robust demand in data centers and energy storage.
- Cboe Global Markets Layoffs: Cboe shares rose 9% following the announcement of a 20% workforce reduction, with first-quarter adjusted EPS at $3.70 and revenue of $728.9 million, both exceeding market expectations, demonstrating the company's commitment to operational optimization.
- Roku's Revenue Beat: Roku's stock increased by 4% after reporting first-quarter revenue of $1.25 billion, surpassing the expected $1.20 billion, with adjusted EBITDA also exceeding estimates, showcasing the company's ongoing growth potential in the streaming market.
See More
